Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults
Peter S. Creticos(Johns Hopkins University), Hendrik Nolte(University of Cologne), K Nékám(National Institute of Oncology), Thomas B. Casale(University of South Florida), Kevin R. Murphy(Boys Town National Research Hospital), David I. Bernstein(Cincinnati Children's Hospital Medical Center), Nancy Liu(Westat (United States)), Robert B. Fisher(University of Edinburgh), Amarjot Kaur(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jennifer Maloney(Regeneron (United States))
Cited by 169
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k